Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: J Subst Abuse Treat. 2021 Mar 27;129:108372. doi: 10.1016/j.jsat.2021.108372

Table 3.

Attitudes about pharmacist provision of public health services among rural and small metro area pharmacists registered with NYS opioid overdose prevention program (n=60), stratified by naloxone dispensation, 2019.

Measures Distribution, n (%)
All Naloxone dispensed (any vs. none) p-value
Total 60 (100.0) 35 (58.33)
 Vaccinations 0.726
  Supportive 56 (93.3) 33 (58.9)
  Not supportive 4 (6.7) 2 (50.0)
 HIV testing 0.023*
  Supportive 45 (75.0) 30 (66.7)
  Not supportive 15 (25.0) 5 (33.3)
 Referral to free HIV testing 0.088
  Supportive 58 (96.7) 35 (60.3)
  Not supportive 2 (3.3) 0 (0.0)
 Information on safe syringe disposal 0.233
  Supportive 59 (98.3) 35 (59.3)
  Not supportive 1 (1.8) 0 (0.0)
 Information on safe syringe use 0.162
  Supportive 56 (93.3) 34 (60.7)
  Not supportive 4 (6.7) 1 (25.0)
 Referrals to medical & social services 0.946
  Supportive 53 (88.3) 31 (58.5)
  Not supportive 7 (11.7) 4 (57.1)
 Referrals to drug treatment 0.190
  Supportive 54 (90.0) 33 (61.1)
  Not supportive 6 (10.0) 2 (33.3)